Atlas Trials

BRAF V600-mutated Lung Carcinoma Treated With the Combination of Dabrafenib-trametinib: a Retrospective Evaluation

Clinical trial NCT04775095 · COMPLETED

Trial details

NCT number
NCT04775095
Sponsor
Intergroupe Francophone de Cancerologie Thoracique
Status
COMPLETED
Study type
OBSERVATIONAL
Non Small Cell Lung CancerBRAF V600 Mutation
Start date
2021-03-08
Primary completion
2021-12-31
Enrollment
163

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.